The final and most important point, further investigation is warranted to explore potential disparities in IL-4 gene polymorphisms between SnRA and SpRA and the molecular mechanisms underlying IL-4-induced production of distinct antibody spectra in RA. The gene discussed is IL4; the disease is rheumatoid arthritis.